Vicki Wing‐Ki Hui

1.2k total citations
42 papers, 681 citations indexed

About

Vicki Wing‐Ki Hui is a scholar working on Epidemiology, Hepatology and Pathology and Forensic Medicine. According to data from OpenAlex, Vicki Wing‐Ki Hui has authored 42 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Epidemiology, 31 papers in Hepatology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Vicki Wing‐Ki Hui's work include Liver Disease Diagnosis and Treatment (36 papers), Hepatitis B Virus Studies (26 papers) and Hepatitis C virus research (26 papers). Vicki Wing‐Ki Hui is often cited by papers focused on Liver Disease Diagnosis and Treatment (36 papers), Hepatitis B Virus Studies (26 papers) and Hepatitis C virus research (26 papers). Vicki Wing‐Ki Hui collaborates with scholars based in Hong Kong, China and South Korea. Vicki Wing‐Ki Hui's co-authors include Grace Lai–Hung Wong, Terry Cheuk‐Fung Yip, Vincent Wai‐Sun Wong, Yee‐Kit Tse, Henry Lik‐Yuen Chan, Lilian Yan Liang, Jimmy Che‐To Lai, Grace Lui, Xinrong Zhang and Hye Won Lee and has published in prestigious journals such as Hepatology, Journal of Hepatology and The American Journal of Gastroenterology.

In The Last Decade

Vicki Wing‐Ki Hui

39 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vicki Wing‐Ki Hui Hong Kong	16	515	397	89	54	52	42	681
Lilian Yan Liang Hong Kong	17	627 1.2×	495 1.2×	104 1.2×	56 1.0×	53 1.0×	40	725
Jimmy Che‐To Lai Hong Kong	14	465 0.9×	349 0.9×	118 1.3×	28 0.5×	31 0.6×	52	612
Sarah May United States	9	659 1.3×	470 1.2×	148 1.7×	45 0.8×	56 1.1×	33	858
Rena K. Fox United States	15	699 1.4×	697 1.8×	53 0.6×	43 0.8×	77 1.5×	26	1.0k
J.F. Sánchez-Ávila Mexico	15	794 1.5×	802 2.0×	70 0.8×	68 1.3×	47 0.9×	50	1.0k
Joy Peter United States	12	536 1.0×	504 1.3×	91 1.0×	63 1.2×	56 1.1×	24	695
Omar Massoud United States	12	398 0.8×	370 0.9×	47 0.5×	21 0.4×	43 0.8×	25	576
Ilaria Serio Italy	9	570 1.1×	366 0.9×	197 2.2×	26 0.5×	34 0.7×	21	750
Sonia Rossi Italy	11	742 1.4×	684 1.7×	58 0.7×	27 0.5×	65 1.3×	14	928
Joaquín Cabezas Spain	18	595 1.2×	507 1.3×	68 0.8×	91 1.7×	35 0.7×	74	870

Countries citing papers authored by Vicki Wing‐Ki Hui

Since Specialization

Citations

This map shows the geographic impact of Vicki Wing‐Ki Hui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vicki Wing‐Ki Hui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vicki Wing‐Ki Hui more than expected).

Fields of papers citing papers by Vicki Wing‐Ki Hui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vicki Wing‐Ki Hui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vicki Wing‐Ki Hui. The network helps show where Vicki Wing‐Ki Hui may publish in the future.

Co-authorship network of co-authors of Vicki Wing‐Ki Hui

This figure shows the co-authorship network connecting the top 25 collaborators of Vicki Wing‐Ki Hui. A scholar is included among the top collaborators of Vicki Wing‐Ki Hui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vicki Wing‐Ki Hui. Vicki Wing‐Ki Hui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hui, Vicki Wing‐Ki, Grace Lai–Hung Wong, Y K Tse, et al.. (2025). Increased risk of HCC in HBeAg-negative indeterminate phase compared with HBeAg-negative chronic infection. Hepatology. 83(1). 156–168. 1 indexed citations

Leung, Y. H., Terry Cheuk‐Fung Yip, Grace Lai–Hung Wong, et al.. (2025). Concomitant Usage of H1‐Antihistamines and Immune Checkpoint Inhibitors on Cancer Patient Survival. Cancer Medicine. 14(1). e70583–e70583.

Tse, Y K, et al.. (2025). Risk of Variceal Hemorrhage in Patients With Cirrhosis Taking Calcium-channel Blockers. Clinical Gastroenterology and Hepatology.

Liang, Lilian Yan, Terry Cheuk‐Fung Yip, Jimmy Che‐To Lai, et al.. (2024). Dynamic Changes in ELF Score Predict Hepatocellular Carcinoma in Chronic Hepatitis B Patients Receiving Antiviral Treatment. Journal of Viral Hepatitis. 31(12). 808–819. 1 indexed citations

Yang, Zeyuan, Vicki Wing‐Ki Hui, Terry Cheuk‐Fung Yip, et al.. (2024). Alcohol-associated hepatitis trends before and following the onset of the COVID-19 pandemic across two distinct cohorts in the United States and Hong Kong. JHEP Reports. 7(1). 101254–101254. 1 indexed citations

Hui, Vicki Wing‐Ki, Terry Cheuk‐Fung Yip, Jimmy Che‐To Lai, et al.. (2024). A pilot integrated model nurse clinic increases the uptake of antiviral treatment for the prevention of mother‐to‐child transmission of HBV. Liver International. 44(10). 2583–2591. 1 indexed citations

Lai, Jimmy Che‐To, Grace Lai–Hung Wong, Yee‐Kit Tse, et al.. (2024). Histological severity, clinical outcomes and impact of antiviral treatment in indeterminate phase of chronic hepatitis B: A systematic review and meta-analysis. Journal of Hepatology. 82(6). 992–1003. 8 indexed citations

Zhang, Xinrong, Terry Cheuk‐Fung Yip, Yee‐Kit Tse, et al.. (2023). Trends in risk factor control and treatment among patients with non‐alcoholic fatty liver disease and type 2 diabetes between 2000 and 2020: A territory‐wide study. Alimentary Pharmacology & Therapeutics. 57(10). 1103–1116. 2 indexed citations

Zhang, Xinrong, Terry Cheuk‐Fung Yip, Yee‐Kit Tse, et al.. (2023). Duration of type 2 diabetes and liver-related events in nonalcoholic fatty liver disease: A landmark analysis. Hepatology. 78(6). 1816–1827. 13 indexed citations

10.

Yip, Terry Cheuk‐Fung, Jimmy Che‐To Lai, Yee‐Kit Tse, et al.. (2023). Long-term use of tenofovir disoproxil fumarate increases fracture risk in elderly patients with chronic hepatitis B. Journal of Hepatology. 80(4). 553–563. 12 indexed citations

11.

Wong, Grace Lai–Hung, Vicki Wing‐Ki Hui, Terry Cheuk‐Fung Yip, et al.. (2022). Universal HBV vaccination dramatically reduces the prevalence of HBV infection and incidence of hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics. 56(5). 869–877. 29 indexed citations

12.

Liang, Lilian Yan, Terry Cheuk‐Fung Yip, Jimmy Che‐To Lai, et al.. (2022). Tenofovir alafenamide is associated with improved alanine aminotransferase and renal safety compared to tenofovir disoproxil fumarate. Journal of Medical Virology. 94(9). 4440–4448. 7 indexed citations

13.

Yip, Terry Cheuk‐Fung, et al.. (2022). Overview of methodologies and statistical strategies in observational studies and meta-analyses on the risk of hepatocellular carcinoma in patients with chronic hepatitis B on entecavir or tenofovir therapy. Hepatoma Research. 2 indexed citations

14.

Yip, Terry Cheuk‐Fung, Vincent Wai‐Sun Wong, Jimmy Che‐To Lai, et al.. (2022). Risk of hepatic decompensation but not hepatocellular carcinoma decreases over time in patients with hepatitis B surface antigen loss. Journal of Hepatology. 78(3). 524–533. 26 indexed citations

15.

Wong, Grace Lai–Hung, Vicki Wing‐Ki Hui, Qingxiong Tan, et al.. (2022). Novel machine learning models outperform risk scores in predicting hepatocellular carcinoma in patients with chronic viral hepatitis. JHEP Reports. 4(3). 100441–100441. 40 indexed citations

16.

Yip, Terry Cheuk‐Fung, Vicki Wing‐Ki Hui, Yee‐Kit Tse, & Grace Lai–Hung Wong. (2021). Statistical strategies for HCC risk prediction models in patients with chronic hepatitis B. Hepatoma Research. 2021. 3 indexed citations

17.

Liang, Lilian Yan, Vincent Wai‐Sun Wong, Vicki Wing‐Ki Hui, et al.. (2021). Sodium‐glucose co‐transporter 2 inhibitors reduce hepatic events in diabetic patients with chronic hepatitis B. 3(4). 261–269. 2 indexed citations

18.

Liang, Lilian Yan, Hye Won Lee, Vincent Wai‐Sun Wong, et al.. (2021). Serum fibrosis index-based risk score predicts hepatocellular carcinoma in untreated patients with chronic hepatitis B. Clinical and Molecular Hepatology. 27(3). 499–509. 13 indexed citations

19.

Yip, Terry Cheuk‐Fung, Vincent Wai‐Sun Wong, Henry Lik‐Yuen Chan, et al.. (2020). Thiazolidinediones reduce the risk of hepatocellular carcinoma and hepatic events in diabetic patients with chronic hepatitis B. Journal of Viral Hepatitis. 27(9). 904–914. 17 indexed citations

20.

Yip, Terry Cheuk‐Fung, Grace Lai–Hung Wong, Vincent Wai‐Sun Wong, et al.. (2019). Reassessing the accuracy of PAGE-B-related scores to predict hepatocellular carcinoma development in patients with chronic hepatitis B. Journal of Hepatology. 72(5). 847–854. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact